Annual EPS
-$30.72
+$88.32+74.19%
31 December 2023
Summary:
Salarius Pharmaceuticals annual earnings per share is currently -$30.72, with the most recent change of +$88.32 (+74.19%) on 31 December 2023. During the last 3 years, it has risen by +$69.28 (+69.28%). SLRX annual EPS is now at all-time high.SLRX EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
-$0.76
+$1.61+67.93%
30 September 2024
Summary:
Salarius Pharmaceuticals quarterly earnings per share is currently -$0.76, with the most recent change of +$1.61 (+67.93%) on 30 September 2024. Over the past year, it has increased by +$4.45 (+85.41%). SLRX quarterly EPS is now -7500.00% below its all-time high of -$0.01, reached on 31 December 2023.SLRX Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
-$6.42
+$4.45+40.94%
30 September 2024
Summary:
Salarius Pharmaceuticals TTM earnings per share is currently -$6.42, with the most recent change of +$4.45 (+40.94%) on 30 September 2024. Over the past year, it has increased by +$50.08 (+88.64%). SLRX TTM EPS is now at all-time high.SLRX TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SLRX EPS Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +74.2% | +85.4% | +88.6% |
3 y3 years | +69.3% | +95.5% | +89.8% |
5 y5 years | +99.5% | +99.5% | +99.5% |
SLRX EPS High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +74.2% | -7500.0% | +98.5% | at high | +94.5% |
5 y | 5 years | at high | +99.5% | -7500.0% | +99.5% | at high | +99.5% |
alltime | all time | at high | +99.8% | -7500.0% | +100.0% | at high | +100.0% |
Salarius Pharmaceuticals EPS History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$0.76(-67.9%) | -$6.42(-40.9%) |
June 2024 | - | -$2.37(-27.7%) | -$10.87(-45.5%) |
Mar 2024 | - | -$3.28(>+9900.0%) | -$19.95(-42.2%) |
Dec 2023 | -$30.72(-74.2%) | -$0.01(-99.8%) | -$34.51(-38.9%) |
Sept 2023 | - | -$5.21(-54.5%) | -$56.50(-44.9%) |
June 2023 | - | -$11.45(-35.8%) | -$102.57(-5.7%) |
Mar 2023 | - | -$17.84(-18.9%) | -$108.72(-7.3%) |
Dec 2022 | -$119.04(+92.7%) | -$22.00(-57.1%) | -$117.28(+3.5%) |
Sept 2022 | - | -$51.28(+191.4%) | -$113.28(+43.9%) |
June 2022 | - | -$17.60(-33.3%) | -$78.72(+4.8%) |
Mar 2022 | - | -$26.40(+46.7%) | -$75.12(+23.7%) |
Dec 2021 | -$61.76(-38.2%) | -$18.00(+7.7%) | -$60.72(-3.2%) |
Sept 2021 | - | -$16.72(+19.4%) | -$62.72(-5.0%) |
June 2021 | - | -$14.00(+16.7%) | -$66.00(-15.4%) |
Mar 2021 | - | -$12.00(-40.0%) | -$78.00(-29.1%) |
Dec 2020 | -$100.00(-76.4%) | -$20.00(0.0%) | -$110.00(-38.2%) |
Sept 2020 | - | -$20.00(-23.1%) | -$178.00(-41.4%) |
June 2020 | - | -$26.00(-40.9%) | -$304.00(-10.1%) |
Mar 2020 | - | -$44.00(-50.0%) | -$338.00(-62.2%) |
Dec 2019 | -$424.00 | -$88.00(-39.7%) | -$894.00(-34.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2019 | - | -$146.00(+143.3%) | -$1356.00(-30.8%) |
June 2019 | - | -$60.00(-90.0%) | -$1960.00(-55.5%) |
Mar 2019 | - | -$600.00(+9.1%) | -$4400.00(-27.9%) |
Dec 2018 | -$6100.00(-38.7%) | -$550.00(-26.7%) | -$6100.00(-22.3%) |
Sept 2018 | - | -$750.00(-70.0%) | -$7850.00(-19.9%) |
June 2018 | - | -$2500.00(+8.7%) | -$9800.00(-0.5%) |
Mar 2018 | - | -$2300.00(0.0%) | -$9850.00(-1.5%) |
Dec 2017 | -$9950.00(-18.1%) | -$2300.00(-14.8%) | -$10.00 K(-1.0%) |
Sept 2017 | - | -$2700.00(+5.9%) | -$10.10 K(-5.2%) |
June 2017 | - | -$2550.00(+4.1%) | -$10.65 K(-8.6%) |
Mar 2017 | - | -$2450.00(+2.1%) | -$11.65 K(-4.9%) |
Dec 2016 | -$12.15 K(+16.8%) | -$2400.00(-26.2%) | -$12.25 K(-1.2%) |
Sept 2016 | - | -$3250.00(-8.5%) | -$12.40 K(+5.1%) |
June 2016 | - | -$3550.00(+16.4%) | -$11.80 K(+11.3%) |
Mar 2016 | - | -$3050.00(+19.6%) | -$10.60 K(+1.0%) |
Dec 2015 | -$10.40 K | -$2550.00(-3.8%) | -$10.50 K(+32.1%) |
Sept 2015 | - | -$2650.00(+12.8%) | -$7950.00(+12.6%) |
June 2015 | - | -$2350.00(-20.3%) | -$7057.91(+6.2%) |
Mar 2015 | - | -$2950.00(+67.8%) | -$6645.65(+79.8%) |
Sept 2014 | - | -$1757.91(-9.3%) | -$3695.65(+90.7%) |
June 2014 | - | -$1937.74 | -$1937.74 |
FAQ
- What is Salarius Pharmaceuticals annual earnings per share?
- What is the all time high annual EPS for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals annual EPS year-on-year change?
- What is Salarius Pharmaceuticals quarterly earnings per share?
- What is the all time high quarterly EPS for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals quarterly EPS year-on-year change?
- What is Salarius Pharmaceuticals TTM earnings per share?
- What is the all time high TTM EPS for Salarius Pharmaceuticals?
- What is Salarius Pharmaceuticals TTM EPS year-on-year change?
What is Salarius Pharmaceuticals annual earnings per share?
The current annual EPS of SLRX is -$30.72
What is the all time high annual EPS for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high annual earnings per share is -$30.72
What is Salarius Pharmaceuticals annual EPS year-on-year change?
Over the past year, SLRX annual earnings per share has changed by +$88.32 (+74.19%)
What is Salarius Pharmaceuticals quarterly earnings per share?
The current quarterly EPS of SLRX is -$0.76
What is the all time high quarterly EPS for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high quarterly earnings per share is -$0.01
What is Salarius Pharmaceuticals quarterly EPS year-on-year change?
Over the past year, SLRX quarterly earnings per share has changed by +$4.45 (+85.41%)
What is Salarius Pharmaceuticals TTM earnings per share?
The current TTM EPS of SLRX is -$6.42
What is the all time high TTM EPS for Salarius Pharmaceuticals?
Salarius Pharmaceuticals all-time high TTM earnings per share is -$6.42
What is Salarius Pharmaceuticals TTM EPS year-on-year change?
Over the past year, SLRX TTM earnings per share has changed by +$50.08 (+88.64%)